A recent study has shown that USP17 can interact with Cdc25A and remove the K48-linked polyubiquitin chains, which target Cdc25A for proteasomal degradation, in order to subvert cell cycle and promote tumor progression [23]. This evidence concerns the gene CDC25A and neoplasm.